National Health Investors
296 hedge funds and large institutions have $2.63B invested in National Health Investors in 2025 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 123 increasing their positions, 78 reducing their positions, and 29 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
66% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 29
58% more repeat investments, than reductions
Existing positions increased: 123 | Existing positions reduced: 78
15% more call options, than puts
Call options by funds: $1.02M | Put options by funds: $886K
4% more funds holding
Funds holding: 284 → 296 (+12)
2% less capital invested
Capital invested by funds: $2.68B → $2.63B (-$50.8M)
39.08% less ownership
Funds ownership: 111.32% → 72.24% (-39%)
Top Buyers
Top Sellers
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$71.3M |
| 2 |
JP Morgan Chase
New York
|
-$48M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$21.2M |
| 4 |
Millennium Management
New York
|
-$6.65M |
| 5 |
Two Sigma Advisers
New York
|
-$5.58M |
NHI Hedge Fund Activity: Q4 2025 in Review
296 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in National Health Investors (NHI) for Q4 2025, worth a combined $2.63B — down 1.9% from $2.68B a quarter earlier.
Buyers outnumbered sellers: 48 funds opened new NHI positions and 29 closed out — a net gain of 19 holders — while 123 added to existing stakes and 78 trimmed.
The largest buyer was Freestone Grove Partners, opening a new position worth an estimated $22M. The largest seller was Macquarie Group, cutting an estimated $71.3M.
- 296 institutional investors held National Health Investors (NHI) as of Q4 2025, up from 284 in Q3 2025.
- Funds reported $2.63B of National Health Investors stock for Q4 2025, down 1.9% quarter-over-quarter.
- 48 funds opened new National Health Investors positions in Q4 2025 and 29 closed out, a net change of +19 holders.
- The largest National Health Investors buyer in Q4 2025 was Freestone Grove Partners, an estimated $22M added.
- The largest National Health Investors seller in Q4 2025 was Macquarie Group, an estimated $71.3M sold.
Based on aggregated 13F filings for Q4 2025.